Latest news
Nautilus Biotechnology, Inc. 2026: Revenue $190K, EPS ($0.11) — 10-Q Summary - TradingViewTradingView · Tue, 28 Jul 2026 20:11:03 GMTNautilus Biotechnology Q2 Earnings Call Highlights - TradingViewTradingView · Tue, 28 Jul 2026 14:04:16 GMTNautilus Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Tue, 28 Jul 2026 13:33:18 GMTNautilus Biotechnology reports Q2 2026: $0.2M revenue, $14.5M net loss, $129.2M cash - TradingViewTradingView · Tue, 28 Jul 2026 10:13:00 GMTNautilus Biotechnology Reports Second Quarter 2026 Financial Results - GlobeNewswireGlobeNewswire · Tue, 28 Jul 2026 07:00:00 GMTNautilus Biotechnology Reports $190,000 Revenue in Second Quarter 2026 - Quiver QuantitativeQuiver Quantitative · Tue, 28 Jul 2026 07:00:00 GMTNautilus Biotechnology (NASDAQ: NAUT) posts $29.2M loss but holds $129.2M in cash and investments - Stock TitanStock Titan · Tue, 28 Jul 2026 07:00:00 GMTNautilus Biotechnology (NASDAQ: NAUT) shifts roadmap after Q2 2026 results - Stock TitanStock Titan · Tue, 28 Jul 2026 07:00:00 GMT